Requires the Director of the Department of Health and Human Services to seek to establish certain rates of reimbursement under Medicaid for certain devices to treat epilepsy. (BDR S-571)

Added a requirement for the Department of Health and Human Services to seek Medicaid reimbursement rates for the procedures necessary to implant, repair, or replace parts of vagus nerve stimulation therapy devices.

Updated the Legislative Counsel's Digest to clarify that the new reimbursement rates for procedures must be separate from and in addition to the rates for the devices and parts themselves.

Revised the bill text to specify that the separate reimbursement requirement applies to the medical care necessary for the implantation or repair of the device, not just the initial implantation or replacement of a part.

Removed the requirement for reimbursement rates covering procedures to implant, repair, or replace parts of vagus nerve stimulation therapy devices.

Simplified the bill's scope to focus only on reimbursement rates for the devices themselves and their replacement parts, rather than including associated medical procedures.

Updated reprint version from Second Reprint to Third Reprint with amendments adopted on June 2, 2025.

Added requirement that vagus nerve stimulation therapy devices must be prescribed for the treatment of epilepsy to qualify for Medicaid reimbursement.

Added a new Section 1 that appropriates specific funding amounts from the State General Fund for computer system upgrades and Medicaid rate increases.

Increased funding amounts for Fiscal Year 2025-2026 from $54,728 to $54,728 and added new authorized expenditures of $188,270 for the same period.

Added Section 3 establishing specific effective dates: July 1, 2025 for Section 1 and March 1, 2026 for Section 2.

Removed the requirement that the act becomes effective upon passage and approval, replacing it with specific calendar dates.